Filomeen Haerynck
Overview
Explore the profile of Filomeen Haerynck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
5492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beyls E, De Beul S, Bordon V, Ferster A, Haerynck F, Vral A, et al.
Mutat Res Genet Toxicol Environ Mutagen
. 2025 Mar;
902:503852.
PMID: 40044379
Genetic defects in one of the DNA double strand break (DSB) repair proteins lead to distinct human syndromes with severe clinical manifestations, including impaired neurological and immunological development, cancer proneness...
2.
Duthoo E, Beyls E, Backers L, Gudjonsson T, Huang P, Jonckheere L, et al.
J Exp Med
. 2025 Mar;
222(5).
PMID: 40029331
Ataxia telangiectasia and Rad3-related (ATR) kinase and its interacting protein ATRIP orchestrate the replication stress response. Homozygous splice variants in the ATRIP gene, resulting in ATRIP deficiency, were identified in...
3.
Beyls E, Duthoo E, Backers L, Claes K, De Bruyne M, Pottie L, et al.
J Clin Immunol
. 2025 Feb;
45(1):75.
PMID: 39945898
Human inborn errors of immunity (IEI) represent a diverse group of genetic disorders affecting the innate and/or adaptive immune system. Some IEI entities comprise defects in DNA repair factors, resulting...
4.
Velthof L, Geldof J, Truyens M, Van Dorpe J, Ferdinande L, De Vriendt C, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860504
: Gastrointestinal diseases are a major cause of morbidity in common variable immunodeficiency disorder (CVID), clinically often mimicking other conditions including celiac disease and inflammatory bowel disease (IBD). Hence, diagnosis...
5.
Seijbel T, Hoste L, Buysse C, Dulfer K, Haerynck F, de Hoog M, et al.
Crit Care Explor
. 2025 Jan;
7(1):e1213.
PMID: 39850487
Objectives: The COVID-19 pandemic gave rise to uncertainty concerning potential sequelae related to a severe acute respiratory syndrome coronavirus 2 infection. This landscape is currently unfolding with studies reporting sequelae...
6.
Mackie J, Suan D, McNaughton P, Haerynck F, OSullivan M, Guerin A, et al.
Clin Exp Immunol
. 2025 Jan;
219(1).
PMID: 39836489
Introduction: Signal transducer and activator of transcription 3 (STAT3) orchestrates crucial immune responses through its pleiotropic functions as a transcription factor. Patients with germline monoallelic dominant negative or hypermorphic STAT3...
7.
Ouedraogo L, Deng L, Ouattara C, Compaore A, Ouedraogo M, Argaw A, et al.
Nutrients
. 2024 Dec;
16(23.
PMID: 39683635
: Small vulnerable newborns (SVNs), including those born preterm, small for gestational age, or with low birth weight, are at higher risk of neonatal mortality and long-term health complications. Early...
8.
Bellos E, Santillo D, Vantourout P, Jackson H, Duret A, Hearn H, et al.
J Exp Med
. 2024 Nov;
221(12).
PMID: 39576310
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We...
9.
Hoste L, Meertens B, Ogunjimi B, Sabato V, Guerti K, van der Hilst J, et al.
Inflammation
. 2024 Nov;
PMID: 39528768
Patients with non-infectious systemic inflammation may suffer from one of many diseases, including hyperinflammation (HI), autoinflammatory disorders (AID), and systemic autoimmune disease (AI). Despite their clinical overlap, the pathophysiology and...
10.
Neirinck J, Buysse M, Brdickova N, Perez-Andres M, De Vriendt C, Kerre T, et al.
Clin Chem Lab Med
. 2024 Oct;
63(3):621-635.
PMID: 39423371
Objectives: The development of External Quality Assessment Schemes (EQAS) for clinical flow cytometry (FCM) is challenging in the context of rare (immunological) diseases. Here, we introduce a novel EQAS monitoring...